ADVANCED COLORECTAL CARCINOMA
Clinical trials for ADVANCED COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in taming tough cancers
Disease control CompletedThis study tested a combination of two drugs, durvalumab (an immunotherapy) and tazemetostat (an epigenetic therapy), in 164 adults with advanced solid tumors like pancreatic, colorectal, and soft-tissue sarcoma. The goal was to see if the combo could shrink or stabilize tumors. …
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a combination of three drugs (TAS-102, irinotecan, and bevacizumab) in 42 people with advanced colorectal cancer that had already been treated and spread or couldn't be removed. The goal was to see if this mix could slow cancer growth better than standard treatm…
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC